{
  "authors": [
    {
      "author": "Wan He"
    },
    {
      "author": "Xiangmei Zhang"
    },
    {
      "author": "Wenwen Li"
    },
    {
      "author": "Cheng Kong"
    },
    {
      "author": "Yuanyang Wang"
    },
    {
      "author": "Lianyu Zhu"
    },
    {
      "author": "Ruilian Xu"
    },
    {
      "author": "Guofang Deng"
    },
    {
      "author": "Peize Zhang"
    }
  ],
  "doi": "10.2147/OTT.S178246",
  "publication_date": "2018-11-15",
  "id": "EN112922",
  "url": "https://pubmed.ncbi.nlm.nih.gov/30425530",
  "source": "OncoTargets and therapy",
  "source_url": "",
  "licence": "CC BY-NC",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "A patient with metastatic melanoma whose pulmonary TB was activated after administration of pembrolizumab for melanoma is reported. Anti-TB drugs were administered, followed by pembrolizumab (2 mg/kg, repeated every 28 days), which successfully cured the TB and achieved complete response for melanoma."
}